ArticleFrontiers in molecular biosciences2025
Cancer immunotherapy and immunomonitoring approached as a future therapy for long-lasting outcomes: outlines of 8th CITIM meeting.
Rostyslav BilyyPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.